Skip to main content
Top
Published in: Journal of Inherited Metabolic Disease 5/2015

01-09-2015 | Original Article

Homogentisate 1,2 dioxygenase is expressed in brain: implications in alkaptonuria

Authors: Giulia Bernardini, Marcella Laschi, Michela Geminiani, Daniela Braconi, Elisa Vannuccini, Pietro Lupetti, Fabrizio Manetti, Lia Millucci, Annalisa Santucci

Published in: Journal of Inherited Metabolic Disease | Issue 5/2015

Login to get access

Abstract

Alkaptonuria is an ultra-rare autosomal recessive disease developed from the lack of homogentisate 1,2-dioxygenase (HGD) activity, causing an accumulation in connective tissues of homogentisic acid (HGA) and its oxidized derivatives in polymerized form. The deposition of ochronotic pigment has been so far attributed to homogentisic acid produced by the liver, circulating in the blood, and accumulating locally. In the present paper, we report the expression of HGD in the brain. Mouse and human brain tissues were positively tested for HGD gene expression by western blotting. Furthermore, HGD expression was confirmed in human neuronal cells that also revealed the presence of six HGD molecular species. Moreover, once cultured in HGA excess, human neuronal cells produced ochronotic pigment and amyloid. Our findings indicate that alkaptonuric brain cells produce the ochronotic pigment in loco and this may contribute to induction of neurological complications.
Appendix
Available only for authorised users
Literature
go back to reference Abs R, Van Vyve M, Willems PJ et al (1992) The association of astrocytoma and pituitary adenoma in a patient with alcaptonuria. J Neurol Sci 108(1):32–4CrossRefPubMed Abs R, Van Vyve M, Willems PJ et al (1992) The association of astrocytoma and pituitary adenoma in a patient with alcaptonuria. J Neurol Sci 108(1):32–4CrossRefPubMed
go back to reference Addis MF, Tanca A, Pagnozzi D et al (2009) Generation of high-quality protein extracts from formalin-fixed, paraffin-embedded tissues. Proteomics 9:3815–3823CrossRefPubMed Addis MF, Tanca A, Pagnozzi D et al (2009) Generation of high-quality protein extracts from formalin-fixed, paraffin-embedded tissues. Proteomics 9:3815–3823CrossRefPubMed
go back to reference Aquaron RR (2011) Alkaptonuria in France: past experience and lessons for the future. J Inherit Metab Dis 34(6):1115–26CrossRefPubMed Aquaron RR (2011) Alkaptonuria in France: past experience and lessons for the future. J Inherit Metab Dis 34(6):1115–26CrossRefPubMed
go back to reference Aquaron R, Fayet G, Barthet C, Désiré S, Viallet F (1995) Parkinson disease and alkaptonuria: fortuitous association or striatonigral ochronosis? Revue Neurol (Paris) 151(1):63–6 Aquaron R, Fayet G, Barthet C, Désiré S, Viallet F (1995) Parkinson disease and alkaptonuria: fortuitous association or striatonigral ochronosis? Revue Neurol (Paris) 151(1):63–6
go back to reference Braconi D, Laschi M, Amato L et al (2010a) Evaluation of anti-oxidant treatments in an in vitro model of alkaptonuric ochronosis. Rheumatology (Oxford) 49:1975–1983CrossRef Braconi D, Laschi M, Amato L et al (2010a) Evaluation of anti-oxidant treatments in an in vitro model of alkaptonuric ochronosis. Rheumatology (Oxford) 49:1975–1983CrossRef
go back to reference Braconi D, Laschi M, Taylor AM et al (2010b) Proteomic and redox-proteomic evaluation of homogentisic acid and ascorbic acid effects on human articular chondrocytes. J Cell Biochem 111:922–932CrossRefPubMed Braconi D, Laschi M, Taylor AM et al (2010b) Proteomic and redox-proteomic evaluation of homogentisic acid and ascorbic acid effects on human articular chondrocytes. J Cell Biochem 111:922–932CrossRefPubMed
go back to reference Braconi D, Bianchini C, Bernardini G et al (2011) Redox-proteomics of the effects of homogentisic acid in an in vitro human serum model of alkaptonuric ochronosis. J Inherit Metab Dis 34(6):1163–76CrossRefPubMed Braconi D, Bianchini C, Bernardini G et al (2011) Redox-proteomics of the effects of homogentisic acid in an in vitro human serum model of alkaptonuric ochronosis. J Inherit Metab Dis 34(6):1163–76CrossRefPubMed
go back to reference Braconi D, Bernardini G, Bianchini C et al (2012) Biochemical and proteomic characterization of alkaptonuric chondrocytes. J Cell Physiol 227(9):3333–3343CrossRefPubMedCentralPubMed Braconi D, Bernardini G, Bianchini C et al (2012) Biochemical and proteomic characterization of alkaptonuric chondrocytes. J Cell Physiol 227(9):3333–3343CrossRefPubMedCentralPubMed
go back to reference Cox TF, Ranganath L (2011) A quantitative assessment of alkaptonuria: testing the reliability of two disease severity scoring systems. J Inherit Metab Dis 34(6):1153–62CrossRefPubMed Cox TF, Ranganath L (2011) A quantitative assessment of alkaptonuria: testing the reliability of two disease severity scoring systems. J Inherit Metab Dis 34(6):1153–62CrossRefPubMed
go back to reference Galdston M, Jm S, Dobriner K (1952) Alcaptonuria and ochronosis; with a report of three patients and metabolic studies in two. Am J Med 13(4):432–52CrossRefPubMed Galdston M, Jm S, Dobriner K (1952) Alcaptonuria and ochronosis; with a report of three patients and metabolic studies in two. Am J Med 13(4):432–52CrossRefPubMed
go back to reference Koutsilieri E, Kornhuber J, Degen HJ et al (1996) U-373 MG glioblastoma and IMR-32 neuroblastoma cell lines express the dopamine and vesicular monoamine transporters. J Neurosci Res 45(3):269–75CrossRefPubMed Koutsilieri E, Kornhuber J, Degen HJ et al (1996) U-373 MG glioblastoma and IMR-32 neuroblastoma cell lines express the dopamine and vesicular monoamine transporters. J Neurosci Res 45(3):269–75CrossRefPubMed
go back to reference Laschi M, Tinti L, Braconi D et al (2012) Homogentisate 1,2 dioxygenase is expressed in human osteoarticular cells: implications in alkaptonuria. J Cell Physiol 227(9):3254–7CrossRefPubMedCentralPubMed Laschi M, Tinti L, Braconi D et al (2012) Homogentisate 1,2 dioxygenase is expressed in human osteoarticular cells: implications in alkaptonuria. J Cell Physiol 227(9):3254–7CrossRefPubMedCentralPubMed
go back to reference Lichtenstein L, Kaplan L (1954) Hereditary ochronosis; pathologic changes observed in two necropsied cases. Am J Pathol 30(1):99–125PubMedCentralPubMed Lichtenstein L, Kaplan L (1954) Hereditary ochronosis; pathologic changes observed in two necropsied cases. Am J Pathol 30(1):99–125PubMedCentralPubMed
go back to reference Link J (1973) Discoloration of the teeth in alkaptonuria (ochronosis) and Parkinsonism. Chronicle 36(5):130PubMed Link J (1973) Discoloration of the teeth in alkaptonuria (ochronosis) and Parkinsonism. Chronicle 36(5):130PubMed
go back to reference Liu W, Prayson RA (2001) Ochronosis brain: 1. Dura mater involvement in ochronosis (alkaptonuria). Arch Pathol Lab Med 125(7):961–3PubMed Liu W, Prayson RA (2001) Ochronosis brain: 1. Dura mater involvement in ochronosis (alkaptonuria). Arch Pathol Lab Med 125(7):961–3PubMed
go back to reference Mangoura D, Theofilopoulos S, Karouzaki S, Tsirimonaki E (2006) 12-O-tetradecanoyl-phorbol-13-acetate-dependent up-regulation of dopaminergic gene expression requires Ras and neurofibromin in human IMR-32 neuroblastoma. J Neurochem 97(Suppl 1):97–103CrossRefPubMed Mangoura D, Theofilopoulos S, Karouzaki S, Tsirimonaki E (2006) 12-O-tetradecanoyl-phorbol-13-acetate-dependent up-regulation of dopaminergic gene expression requires Ras and neurofibromin in human IMR-32 neuroblastoma. J Neurochem 97(Suppl 1):97–103CrossRefPubMed
go back to reference Mathieu P, Prevel A, David L et al (1997) Screening infants for neuroblastoma: discovery of alkaptonuria in one case. Clin Chim Acta 264(2):255–9CrossRefPubMed Mathieu P, Prevel A, David L et al (1997) Screening infants for neuroblastoma: discovery of alkaptonuria in one case. Clin Chim Acta 264(2):255–9CrossRefPubMed
go back to reference Millucci L, Ghezzi L, Paccagnini E et al (2014c) Amyloidosis, inflammation, and oxidative stress in the heart of an alkaptonuric patient. Mediators Inflamm 2014:258471PubMedCentralPubMed Millucci L, Ghezzi L, Paccagnini E et al (2014c) Amyloidosis, inflammation, and oxidative stress in the heart of an alkaptonuric patient. Mediators Inflamm 2014:258471PubMedCentralPubMed
go back to reference Millucci L, Giorgetti G, Viti C, et al (2014d) Chondroptosis in alkaptonuric cartilage. J Cell Physiol. In press Millucci L, Giorgetti G, Viti C, et al (2014d) Chondroptosis in alkaptonuric cartilage. J Cell Physiol. In press
go back to reference Nishimori I, Ito J, Hakuno T (1970) An autopsy case of alkaptonuria with ochronosis. Acta Pathol Jpn 20(4):505–12PubMed Nishimori I, Ito J, Hakuno T (1970) An autopsy case of alkaptonuria with ochronosis. Acta Pathol Jpn 20(4):505–12PubMed
go back to reference Ranganath LR, Cox TF (2011) Natural history of alkaptonuria revisited: analyses based on scoring systems. J Inherit Metab Dis 34(6):1141–51CrossRefPubMed Ranganath LR, Cox TF (2011) Natural history of alkaptonuria revisited: analyses based on scoring systems. J Inherit Metab Dis 34(6):1141–51CrossRefPubMed
go back to reference Ranganath LR, Milan AM, Hughes AT, et al (2014) Suitability Of Nitisinone In Alkaptonuria 1 (SONIA 1): an international, multicentre, randomised, open-label, no-treatment controlled, parallel-group, dose–response study to investigate the effect of once daily nitisinone on 24-h urinary homogentisic acid excretion in patients with alkaptonuria after 4 weeks of treatment. Ann Rheum Dis. In press Ranganath LR, Milan AM, Hughes AT, et al (2014) Suitability Of Nitisinone In Alkaptonuria 1 (SONIA 1): an international, multicentre, randomised, open-label, no-treatment controlled, parallel-group, dose–response study to investigate the effect of once daily nitisinone on 24-h urinary homogentisic acid excretion in patients with alkaptonuria after 4 weeks of treatment. Ann Rheum Dis. In press
go back to reference Rovensky J (2013) Manifestations of alkaptonuria and ochronosis in visceral organs. In Rovensky J, Urbanek T, Boldisova O, (eds.) Alkaptonuria and ochronosis. Springer, Berlin, p 73–78. Rovensky J (2013) Manifestations of alkaptonuria and ochronosis in visceral organs. In Rovensky J, Urbanek T, Boldisova O, (eds.) Alkaptonuria and ochronosis. Springer, Berlin, p 73–78.
go back to reference Siekert RG, Gibilisco JA (1970) Discoloration of the teeth in alkaptonuria (ochronosis) and parkinsonism. Oral Surg Oral Med Oral Pathol 29(2):197–9CrossRefPubMed Siekert RG, Gibilisco JA (1970) Discoloration of the teeth in alkaptonuria (ochronosis) and parkinsonism. Oral Surg Oral Med Oral Pathol 29(2):197–9CrossRefPubMed
go back to reference Spreafico A, Millucci L, Ghezzi L et al (2013) Antioxidants inhibit SAA formation and pro-inflammatory cytokine release in a human cell model of alkaptonuria. Rheumatology (Oxford) 52(9):1667–73CrossRef Spreafico A, Millucci L, Ghezzi L et al (2013) Antioxidants inhibit SAA formation and pro-inflammatory cytokine release in a human cell model of alkaptonuria. Rheumatology (Oxford) 52(9):1667–73CrossRef
go back to reference Su AI, Wiltshire T, Batalov S et al (2004) A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci U S A 101(16):6062–7CrossRefPubMedCentralPubMed Su AI, Wiltshire T, Batalov S et al (2004) A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci U S A 101(16):6062–7CrossRefPubMedCentralPubMed
go back to reference Tinti L, Spreafico A, Braconi D et al (2010) Evaluation of antioxidant drugs for the treatment of ochronotic alkaptonuria in an in vitro human cell model. J Cell Physiol 225:84–91CrossRefPubMed Tinti L, Spreafico A, Braconi D et al (2010) Evaluation of antioxidant drugs for the treatment of ochronotic alkaptonuria in an in vitro human cell model. J Cell Physiol 225:84–91CrossRefPubMed
go back to reference Tinti L, Spreafico A, Chellini F, Galeazzi M, Santucci A (2011a) A novel ex vivo organotypic culture model of alkaptonuria-ochronosis. Clin Exp Rheumatol 29(4):693–6PubMed Tinti L, Spreafico A, Chellini F, Galeazzi M, Santucci A (2011a) A novel ex vivo organotypic culture model of alkaptonuria-ochronosis. Clin Exp Rheumatol 29(4):693–6PubMed
go back to reference Tinti L, Taylor AM, Santucci A et al (2011b) Development of an in vitro model to investigate joint ochronosis in alkaptonuria. Rheumatology (Oxford) 50(2):271–7CrossRef Tinti L, Taylor AM, Santucci A et al (2011b) Development of an in vitro model to investigate joint ochronosis in alkaptonuria. Rheumatology (Oxford) 50(2):271–7CrossRef
Metadata
Title
Homogentisate 1,2 dioxygenase is expressed in brain: implications in alkaptonuria
Authors
Giulia Bernardini
Marcella Laschi
Michela Geminiani
Daniela Braconi
Elisa Vannuccini
Pietro Lupetti
Fabrizio Manetti
Lia Millucci
Annalisa Santucci
Publication date
01-09-2015
Publisher
Springer Netherlands
Published in
Journal of Inherited Metabolic Disease / Issue 5/2015
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-015-9829-5

Other articles of this Issue 5/2015

Journal of Inherited Metabolic Disease 5/2015 Go to the issue